Clearance Summary
GLYCO-SEP/ALC TEST KIT FOR SEPARAT OF HEMOGLOBIN received FDA 510(k) clearance under submission number K852986, sponsored by Clinical Technology Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1985-08-19.
- Submission: K852986
- Applicant / Sponsor: Clinical Technology Corp.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7470
- Decision date: 1985-08-19
Classification & Regulation
This clearance is catalogued under FDA product code LCP and 21 CFR 864.7470, within the Hematology review panel as a Class II device.